DE69413523D1 - Benzimidazole derivate - Google Patents
Benzimidazole derivateInfo
- Publication number
- DE69413523D1 DE69413523D1 DE69413523T DE69413523T DE69413523D1 DE 69413523 D1 DE69413523 D1 DE 69413523D1 DE 69413523 T DE69413523 T DE 69413523T DE 69413523 T DE69413523 T DE 69413523T DE 69413523 D1 DE69413523 D1 DE 69413523D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- date sep
- benzimidazole derivatives
- sec
- pub
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939305628A GB9305628D0 (en) | 1993-03-18 | 1993-03-18 | Therapeutic agents |
GB939316258A GB9316258D0 (en) | 1993-08-05 | 1993-08-05 | Therapeutic agents |
PCT/GB1994/000528 WO1994021615A1 (en) | 1993-03-18 | 1994-03-16 | Benzimidazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69413523D1 true DE69413523D1 (de) | 1998-10-29 |
DE69413523T2 DE69413523T2 (de) | 1999-05-12 |
Family
ID=26302612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69413523T Expired - Fee Related DE69413523T2 (de) | 1993-03-18 | 1994-03-16 | Benzimidazole derivate |
Country Status (9)
Country | Link |
---|---|
US (1) | US5714498A (de) |
EP (1) | EP0689535B1 (de) |
JP (1) | JPH08508030A (de) |
AT (1) | ATE171447T1 (de) |
AU (1) | AU679045B2 (de) |
CA (1) | CA2156836A1 (de) |
DE (1) | DE69413523T2 (de) |
ES (1) | ES2121193T3 (de) |
WO (1) | WO1994021615A1 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9604036D0 (en) * | 1996-02-26 | 1996-04-24 | Merck Sharp & Dohme | Therapeutic agents |
US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
GB9605065D0 (en) * | 1996-03-11 | 1996-05-08 | Merck Sharp & Dohme | Therapeutic agents |
US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
CA2324268A1 (en) | 1998-03-18 | 1999-09-23 | Taisho Pharmaceutical Co., Ltd. | Aromaheterocyclic derivatives |
US6407121B1 (en) | 1998-03-19 | 2002-06-18 | Nihon Nohyaku Co., Ltd. | Arylpiperidine derivatives and use thereof |
US6589954B1 (en) * | 1998-05-22 | 2003-07-08 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
US6867209B1 (en) | 1998-05-22 | 2005-03-15 | Scios, Inc. | Indole-type derivatives as inhibitors of p38 kinase |
US6448257B1 (en) | 1998-05-22 | 2002-09-10 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
US6130235A (en) * | 1998-05-22 | 2000-10-10 | Scios Inc. | Compounds and methods to treat cardiac failure and other disorders |
US6340685B1 (en) | 1998-05-22 | 2002-01-22 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
IL146309A (en) * | 1999-05-21 | 2008-03-20 | Scios Inc | Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38 |
US6316474B1 (en) | 1999-10-29 | 2001-11-13 | Merck & Co., Inc. | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
US6369076B1 (en) * | 1999-10-29 | 2002-04-09 | Merck & Co. Inc. | 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists |
US6476041B1 (en) * | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
US6489477B1 (en) | 1999-10-29 | 2002-12-03 | Merck & Co., Inc. | 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists |
US6291499B1 (en) * | 1999-10-29 | 2001-09-18 | Merck & Co., Inc. | 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
EP1235572A2 (de) * | 1999-10-29 | 2002-09-04 | MERCK SHARP & DOHME LTD. | Schmerzbehandlungsmethode mit benzimidazol nmda/nr2b antagonisten |
US6380205B1 (en) | 1999-10-29 | 2002-04-30 | Merck & Co., Inc. | 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
US6432976B1 (en) * | 1999-10-29 | 2002-08-13 | Merck & Co., Inc. | 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists |
US6495561B2 (en) | 1999-10-29 | 2002-12-17 | Merck & Co., Inc. | 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
US7842068B2 (en) * | 2000-12-07 | 2010-11-30 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
US6806275B2 (en) | 2000-09-13 | 2004-10-19 | Nihon Nohyaku Co., Ltd. | Arylpiperidine derivatives and use thereof |
UA75392C2 (en) | 2001-02-23 | 2006-04-17 | Merck & Co Inc | N-substituted non-aryl heterocyclic antagonists nmda/nr2b |
US7022728B2 (en) * | 2001-03-09 | 2006-04-04 | Abbott Laboratories | Benzimidazoles that are useful in treating male sexual dysfunction |
US6960589B2 (en) * | 2001-03-09 | 2005-11-01 | Abbott Laboratories | Benzimidazoles that are useful in treating sexual dysfunction |
CA2443108A1 (en) | 2001-04-03 | 2002-10-17 | Merck & Co. Inc. | N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
US20040127504A1 (en) * | 2002-09-06 | 2004-07-01 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
US7592360B2 (en) | 2003-06-04 | 2009-09-22 | Merck & Co., Inc. | 3-fluoro-piperidines as NMDA/NR2B antagonists |
GB0503646D0 (en) * | 2005-02-22 | 2005-03-30 | Novartis Ag | Organic compounds |
GB0508318D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
GB0508314D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
GB0508319D0 (en) | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
WO2012087833A1 (en) | 2010-12-22 | 2012-06-28 | Abbott Laboratories | Hepatitis c inhibitors and uses thereof |
RS63849B9 (sr) | 2016-12-16 | 2023-06-30 | Pfizer | Agonisti glp-1 receptora i njihova upotreba |
US10934279B2 (en) | 2018-06-13 | 2021-03-02 | Pfizer Inc. | GLP-1 receptor agonists and uses thereof |
CA3236708A1 (en) | 2021-10-25 | 2023-05-04 | Terns Pharmaceuticals, Inc. | Compounds as glp-1r agonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1417745A (en) * | 1973-07-07 | 1975-12-17 | Beecham Group Ltd | Chromene compounds |
EP0034249B1 (de) * | 1980-02-08 | 1984-10-24 | Gruppo Lepetit S.P.A. | Naphthimidazol- und Naphthoxazol-Derivate, ihre Herstellung und ihre Verwendung in Pharmazeutika |
PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
JP2643168B2 (ja) * | 1987-08-24 | 1997-08-20 | エーザイ株式会社 | 不整脈治療・予防剤 |
CA2022451C (en) * | 1989-08-03 | 2001-01-23 | Albert Anthony Carr | Anti-psychotic piperidynl benzimidazole compounds |
US5169855A (en) * | 1990-03-28 | 1992-12-08 | Du Pont Merck Pharmaceutical Company | Piperidine ether derivatives as psychotropic drugs or plant fungicides |
-
1994
- 1994-03-16 US US08/530,099 patent/US5714498A/en not_active Expired - Fee Related
- 1994-03-16 DE DE69413523T patent/DE69413523T2/de not_active Expired - Fee Related
- 1994-03-16 AT AT94909233T patent/ATE171447T1/de not_active IP Right Cessation
- 1994-03-16 JP JP6520781A patent/JPH08508030A/ja active Pending
- 1994-03-16 WO PCT/GB1994/000528 patent/WO1994021615A1/en active IP Right Grant
- 1994-03-16 ES ES94909233T patent/ES2121193T3/es not_active Expired - Lifetime
- 1994-03-16 EP EP94909233A patent/EP0689535B1/de not_active Expired - Lifetime
- 1994-03-16 AU AU62156/94A patent/AU679045B2/en not_active Ceased
- 1994-03-16 CA CA002156836A patent/CA2156836A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1994021615A1 (en) | 1994-09-29 |
EP0689535B1 (de) | 1998-09-23 |
EP0689535A1 (de) | 1996-01-03 |
CA2156836A1 (en) | 1994-09-29 |
JPH08508030A (ja) | 1996-08-27 |
AU6215694A (en) | 1994-10-11 |
DE69413523T2 (de) | 1999-05-12 |
ATE171447T1 (de) | 1998-10-15 |
ES2121193T3 (es) | 1998-11-16 |
AU679045B2 (en) | 1997-06-19 |
US5714498A (en) | 1998-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE171447T1 (de) | Benzimidazole derivate | |
FI954944A0 (fi) | Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon | |
HK1026691A1 (en) | Substituted benzimidazoles and their use for treating retroviral infection | |
ATE199552T1 (de) | Substituierte benzolaktamverbindungen als substanz-p-antagonisten | |
ES2108120T3 (es) | Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf. | |
ID29552A (id) | Senyawa-senyawa triazola dan penggunaannya | |
BR9806752A (pt) | Ftalazinonas. | |
ES2134929T3 (es) | Derivados de pirrolo-piridina como ligandos para receptores de dopamina. | |
DE69415341D1 (de) | Kondensierte tricyclische heteroaromatische derivate als liganden des dopamin-rezeptor-subtyps | |
TR199701536T1 (xx) | Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�. | |
DE69521037D1 (de) | Chinazolinylamino derivate mit alfa-antagonist wirkung | |
AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
TR199902094T2 (xx) | 3-Heteroareil-4(3H)-kinazolinonlar�n atropizomerleri. | |
DE69407191D1 (de) | Kondensierte tricyclische heteroaromatische verbindungen als dopamin-rezeptor-subtyp-liganden | |
ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
ATE169019T1 (de) | Xanthinderivate als adenosin-a1 rezeptor antagonisten | |
ES2166830T3 (es) | Derivados 2,7-sustituidos de octahidro-1h-pirido(1,2-a)pirazina. | |
ES2088661T3 (es) | Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos. | |
FI953002A0 (fi) | Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla | |
BR0014145A (pt) | Compostos de benzimidazol substituìdo por alcóxi, preparações farmacêuticas contendo o mesmo, e métodos de uso do mesmo | |
ATE255112T1 (de) | 1-3 dioxolo/4.5-h//2,3-benzodiazepin derivate als ampa/kainate-rezeptor-hemmer | |
ES2119454T3 (es) | Derivados de pirrolidina para el tratamiento de los desordenes relacionados con la csk y la gastrina. | |
DE69923982D1 (de) | Verwendung einer zusammensetzung enthaltend eine assoziation eines angiotensin ii at1 rezeptor antagonists und indomethacin zur herstellung eines arzneimittels zur behandlung von kronischen glomerulonephriten | |
DK0750502T3 (da) | Anvendelse af phosphorderivater af alkaloider til behandling af endokrinopatier | |
DK0967986T3 (da) | Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |